Check out my lastest publication on Allergic bronchopulmonary aspergillosis in the Journal of Allergy and Asthma. It looks at patients with a severe from of asthma caused by mold sensitivity who were treated with Xolair (omalizumab). We showed that there was a decrease in oral corticosteroid use in these patients. Using xolair might be an additional treatment modality for this difficult to treat group.
http://www.dovepress.com/articles.php?article_id=11467
http://www.dovepress.com/articles.php?article_id=11467I hope you find it interesting and helpful.